Dr Reddy’s, a leading pharmaceutical company in India, has made a
significant entry into the trade generics sector in the Indian market with
its latest venture, RGenX. The move highlights the company’s commitment to
expanding its product portfolio and diversifying its offerings. RGenX aims
to provide affordable and high-quality generic medicines to meet the
healthcare needs of the Indian population. This strategic move by Dr
Reddy’s signifies its ambition to tap into the growing demand for generic
pharmaceuticals in India and contribute to making healthcare more
accessible and affordable for the masses.
significant entry into the trade generics sector in the Indian market with
its latest venture, RGenX. The move highlights the company’s commitment to
expanding its product portfolio and diversifying its offerings. RGenX aims
to provide affordable and high-quality generic medicines to meet the
healthcare needs of the Indian population. This strategic move by Dr
Reddy’s signifies its ambition to tap into the growing demand for generic
pharmaceuticals in India and contribute to making healthcare more
accessible and affordable for the masses.
